NASDAQ:LPNT - LifePoint Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$64.99
Today's Range$64.99 - $64.99
52-Week Range$41.45 - $65.35
VolumeN/A
Average Volume538,571 shs
Market Capitalization$2.52 billion
P/E Ratio17.90
Dividend YieldN/A
Beta0.51
LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. The company's hospitals also offer outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy. In addition, it owns and operates schools of nursing and other allied health professions. As of December 31, 2017, the company operated 71 hospital campuses with a total of 9,254 licensed beds in 22 states. The company was formerly known as LifePoint Hospitals, Inc. and changed its name to LifePoint Health, Inc. in May 2015. LifePoint Health, Inc. was founded in 1997 and is based in Brentwood, Tennessee.

Receive LPNT News and Ratings via Email

Sign-up to receive the latest news and ratings for LPNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
Current SymbolNASDAQ:LPNT
CUSIP53219L10
Phone615-920-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.26 billion
Book Value$60.30 per share

Profitability

Net Income$102.40 million

Miscellaneous

Employees42,000
Market Cap$2.52 billion
OptionableOptionable

LifePoint Health (NASDAQ:LPNT) Frequently Asked Questions

What is LifePoint Health's stock symbol?

LifePoint Health trades on the NASDAQ under the ticker symbol "LPNT."

How will LifePoint Health's stock buyback program work?

LifePoint Health declared that its board has approved a stock repurchase program on Friday, October 27th 2017, which authorizes the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company's board believes its shares are undervalued.

How were LifePoint Health's earnings last quarter?

LifePoint Health Inc (NASDAQ:LPNT) posted its earnings results on Friday, October, 26th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.99 by $0.25. The company had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.55 billion. LifePoint Health had a net margin of 0.59% and a return on equity of 7.80%. The business's revenue was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.80 EPS. View LifePoint Health's Earnings History.

When is LifePoint Health's next earnings date?

LifePoint Health is scheduled to release their next quarterly earnings announcement on Friday, February 22nd 2019. View Earnings Estimates for LifePoint Health.

What price target have analysts set for LPNT?

13 brokers have issued 12-month price targets for LifePoint Health's shares. Their predictions range from $46.00 to $74.00. On average, they expect LifePoint Health's share price to reach $59.5455 in the next twelve months. View Analyst Price Targets for LifePoint Health.

What is the consensus analysts' recommendation for LifePoint Health?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifePoint Health in the last year. There are currently 12 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for LifePoint Health.

What are Wall Street analysts saying about LifePoint Health stock?

Here are some recent quotes from research analysts about LifePoint Health stock:
  • 1. According to Zacks Investment Research, "LifePoint Health, Inc.’s shares have outperformed its industry’s growth in the past six months. Moreover, the company has witnessed its 2018 earnings estimates move upward over the past seven days. It is in the process of being merged with RCCH HealthCare Partners, which would add scale and size to the business. Its acquisition pipeline remains strong with several opportunities in hospitals, health systems and end-market transactions for expansion of its key services. Nevertheless, the company is suffering from low patient admissions which remains a headwind. A pullback of insurers from public exchanges has increased the uninsured rate, which is hurting the company. Its admissions are likely to remain under pressure as it continues to divest its hospitals. Escalating expenses is another concern for the company." (10/23/2018)
  • 2. Cantor Fitzgerald analysts commented, "LPNT reported in-line 4Q17 results, with revenue that is short of the FactSet consensus but adjusted EBITDA that was in-line. The company has, however, increased its provision for bad debt, and includes the new, more accurate estimate as an adjustment." (2/23/2018)

Has LifePoint Health been receiving favorable news coverage?

News headlines about LPNT stock have trended very positive on Tuesday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. LifePoint Health earned a media sentiment score of 3.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are some of LifePoint Health's key competitors?

Who are LifePoint Health's key executives?

LifePoint Health's management team includes the folowing people:
  • Mr. William F. Carpenter III, Chairman & CEO (Age 63)
  • Mr. David M. Dill, Pres & COO (Age 49)
  • Mr. Michael S. Coggin, Exec. VP & CFO (Age 48)
  • Mr. John P. Bumpus, Exec. VP & Chief Admin. Officer (Age 57)
  • John Michael Grooms, VP and Chief Accounting Officer (Age 40)

How do I buy shares of LifePoint Health?

Shares of LPNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is LifePoint Health?

LifePoint Health has a market capitalization of $0.00 and generates $7.26 billion in revenue each year. The company earns $102.40 million in net income (profit) each year or $3.63 on an earnings per share basis. LifePoint Health employs 42,000 workers across the globe.

What is LifePoint Health's official website?

The official website for LifePoint Health is http://www.lifepointhealth.net.

How can I contact LifePoint Health?

LifePoint Health's mailing address is 330 Seven Springs Way, Brentwood TN, 37027. The company can be reached via phone at 615-920-7000 or via email at [email protected]


MarketBeat Community Rating for LifePoint Health (NASDAQ LPNT)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  339 (Vote Outperform)
Underperform Votes:  545 (Vote Underperform)
Total Votes:  884
MarketBeat's community ratings are surveys of what our community members think about LifePoint Health and other stocks. Vote "Outperform" if you believe LPNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LPNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel